Q uality of life (QoL) can be defined as a general sense of well being which is determined by multidimensional factors related to the individual, social interactions and the environment in the context of a given culture and value system. It also relates to the individuals own perception of their position in life in relation to their goals, expectations and concerns, and therefore should be truly judged by the individuals themselves 1,2 . Although health status has been considered to be a key factor in determining QoL, several authors have found low level of agreement between reports from individuals with chronic diseases and their caregivers regarding health-related QoL (HRQoL) estimations. This is particularly true with respect to Parkinson's disease (PD), which is a multifaceted and symptomatically complex neurodegenerative condition 3 . PD is the second most common neurodegenerative disorder and is characterized by the classical motor symptoms (resting tremor, bradykinesia, rigidity, postural instability) and nonmotor symptoms, some of which may precede clinical diagnosis by several years. Non-motor symptoms include autonomic dysfunction (constipation, urinary), cognitive decline (memory and attention), psychiatric disorders (depression, anxiety), sleep disturbances (vivid dreams, REM behavior disorder) and fatigue, among others. HRQoL in PD is determined by motor and non-motor symptoms and by the effects of treatment as well (efficacy and side effects) 4 . As the disease progresses, patients with PD are particularly prone to deterioration of HRQoL as a result of both increased motor disability and the burden of non-motor symptoms. Among motor symptoms, the main determinants are disease severity, motor complications of treatment, postural instability, and gait disturbances
5. Among non-motor symptoms, depression has been recognized as the main HRQoL determinant but other symptoms such as anxiety, cognitive impairment, fatigue, sleep disorders, pain and dysautonomia are also major contributors to low HRQoL in PD 6 . Several rating scales have been used to assess disease severity and HRQoL in PD. The most widely used include: Hoehn and Yahr staging (HY), Non-MotorSymptoms Scale (NMSS), MDS-UPDRS, Parkinson's Disease Questionnaire (PDQ-39) and its eight item-short version (PDQ-8).The NMSS include the following domains:cardiovascular, sleep/fatigue, mood, perceptual, attention/memory, gastrointestinal, urinary and sexual function. The MDS-UPDRS is composed of four subscales:Part I,non-motor experiences of daily living; Part II, motor experiences of daily living; Part III, motor examination; and Part IV, motor complications. Items are scored on a five-point scale, ranging from 0 (normal)to 4 (severe), and the total score is obtained for each section.The PDQ-8 has eight items scoring from 0 (never) to 4 (always) and provides judgments about the impact of PD on physical, mental and social domains. The summary index (SI) is expressed as the percentage of the sum of item scores on the maximum possible score (32points)...